| Reduced Risk Status: |
|
| IPM Compatibility: |
PER WSR/NCR NOMINATION COMMENTS: NOT A GOOD IPM FIT, BUT MAY PROVIDE SOME RESISTANCE MANAGEMENT IN A ROTATION WITH UNLIKE PRODUCTS; PYRETHROIDS HAVE NOT BEEN USED IN PNW CHERRY IPM PROGRAMS DUE TO IMPACT ON BENEFICIALS; THESE PROGRAMS HAVE RECENTLY HAD TO INCORPORATE PYRETHROID USE BECAUSE OF SPOTTED WING DROSOPHILA (SWD); PYRETHROIDS ARE ONE OF FEW CLASSES OF INSECTICIDES EFFECTIVE AGAINST SWD; BECAUSE OF PYRETHROID IMPACTS ON BENEFICIALS, MORE OUTBREAKS OF SPIDER MITES ARE OCCURRING; INTRODUCING ANOTHER PYRETHROID INTO CHERRY PRODUCTION FOR THE CONTROL OF BROWN MARMORATED STINK BUG (BMSB) WON'T MAKE A DIFFERENCE IN THE PYRETHROID-INDUCED PROBLEMS THAT ARE ALREADY BEING SEEN IN CHERRY IPM PROGRAMS; BIFENTHRIN IS ONE OF THE BETTER PYRETHROIDS AT MANAGING BMSB AND CHERRY GROWERS WILL NEED BETTER MATERIALS NOW THAT BMSB IS GETTING ESTABLISHED IN OR AND WA; BIFENTHRIN WILL ALSO BE USEFUL IN CHERRY IPM PROGRAMS IF IT HAS A SHORT PHI AND IF EXPORT TOLERANCES ARE ESTABLISHED THAT SUPPORT EXPORT MARKETS; USE IS BEST FOR LATE SEASON APPLICATIONS TO AVOID POLLINATORS SO THAT LOWER RISK PRODUCTS CAN BE USED EARLY IN THE SEASON
|
| Reasons for need: |
BROWN MARMORATED STINK BUG
|
| Requesting State(s): |
MD:Butler, B. ; MI:Wise, J. ; NJ:Nielsen, A. ; OR:DeFrancesco, J. ; PA:Krawczyk, G. ;
|
| PCR Use Pattern: |
0.1 LB AI/A, 0.2 LB AI/A; 3 FOLIAR APPLIC; 30-DAY RE-TREATMENT INTERVALS; 14-DAY PHI
|
| EPA Default Residue Trials: |
SOUR: 1 5-5 9 11/12; SWEET: 5-2 10-2 11-3 12
|
| IR-4 Residue Trial Plan: |
TART: 1 5-2 9; SWEET: 5 10 11-2
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
MFG CONCERNED ONLY ABOUT CROP SAFETY (CS); MUST DOCUMENT CS IN RESIDUE TRIALS:06/14; EPA (HOLD) CAUTION:08/14; ADAMA WILL NOT SUPPORT:09/14
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|